Organon & Co
XMUN:7XP

Watchlist Manager
Organon & Co Logo
Organon & Co
XMUN:7XP
Watchlist
Price: 5.918 EUR Market Closed
Market Cap: 1.5B EUR

Relative Value

The Relative Value of one 7XP stock under the Base Case scenario is hidden EUR. Compared to the current market price of 5.918 EUR, Organon & Co is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

7XP Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
94
vs Industry
80
Median 3Y
0.7
Median 5Y
0.8
Industry
2.6
Forward
0.3
vs History
78
vs Industry
43
Median 3Y
4.7
Median 5Y
4.9
Industry
21.7
Forward
1.9
vs History
94
vs Industry
49
Median 3Y
5.1
Median 5Y
4.8
Industry
16.7
vs History
63
vs Industry
2
Median 3Y
10.1
Median 5Y
8
Industry
23.1
vs History
35
vs Industry
8
Median 3Y
2.2
Median 5Y
-4.4
Industry
2.2
vs History
92
vs Industry
52
Median 3Y
2
Median 5Y
2.1
Industry
2.9
Forward
1.6
vs History
92
vs Industry
57
Median 3Y
3.3
Median 5Y
3.5
Industry
5.5
vs History
92
vs Industry
41
Median 3Y
7.3
Median 5Y
7.2
Industry
13.2
Forward
5.1
vs History
84
vs Industry
40
Median 3Y
8.6
Median 5Y
8.2
Industry
16.8
Forward
5.8
vs History
77
vs Industry
32
Median 3Y
14.4
Median 5Y
13.3
Industry
15.9
vs History
71
vs Industry
22
Median 3Y
22.4
Median 5Y
20.7
Industry
19.2
vs History
94
vs Industry
55
Median 3Y
1.2
Median 5Y
1.3
Industry
1.9

Multiples Across Competitors

7XP Competitors Multiples
Organon & Co Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Organon & Co
XMUN:7XP
1.8B EUR 0.3 3.7 5.9 7.3
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.1 55.3 37.1 39.8
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
500B USD 5.4 19.9 16.3 21.1
CH
Roche Holding AG
SIX:ROG
262.5B CHF 4.3 27.8 11.9 13.9
UK
AstraZeneca PLC
LSE:AZN
212B GBP 4.9 30.5 108.5 158.8
CH
Novartis AG
SIX:NOVN
211.3B CHF 4.8 18.6 11.8 15.2
US
Merck & Co Inc
NYSE:MRK
264.8B USD 4.1 13.9 9.9 11.7
DK
Novo Nordisk A/S
CSE:NOVO B
1.5T DKK 4.7 14.2 9.9 11.5
IE
Endo International PLC
LSE:0Y5F
209B USD 90.1 -71.5 331.1 830.4
US
Pfizer Inc
NYSE:PFE
142.3B USD 2.3 14.5 7.4 10.1
P/E Multiple
Earnings Growth PEG
US
Organon & Co
XMUN:7XP
Average P/E: 22
3.7
7%
0.5
US
Eli Lilly and Co
NYSE:LLY
55.3
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.9
29%
0.7
CH
Roche Holding AG
SIX:ROG
27.8
29%
1
UK
AstraZeneca PLC
LSE:AZN
30.5
38%
0.8
CH
Novartis AG
SIX:NOVN
18.6
17%
1.1
US
Merck & Co Inc
NYSE:MRK
13.9
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
14.2
4%
3.5
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -71.5 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.5
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Organon & Co
XMUN:7XP
Average EV/EBITDA: 399.6
5.9
5%
1.2
US
Eli Lilly and Co
NYSE:LLY
37.1
33%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.3
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.9
4%
3
UK
AstraZeneca PLC
LSE:AZN
108.5
10%
10.8
CH
Novartis AG
SIX:NOVN
11.8
6%
2
US
Merck & Co Inc
NYSE:MRK
9.9
6%
1.6
DK
Novo Nordisk A/S
CSE:NOVO B
9.9
2%
5
IE
E
Endo International PLC
LSE:0Y5F
331.1
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.4
1%
7.4
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Organon & Co
XMUN:7XP
Average EV/EBIT: 1 711.1
7.3
7%
1
US
Eli Lilly and Co
NYSE:LLY
39.8
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.1
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.9
5%
2.8
UK
AstraZeneca PLC
LSE:AZN
158.8
23%
6.9
CH
Novartis AG
SIX:NOVN
15.2
12%
1.3
US
Merck & Co Inc
NYSE:MRK
11.7
8%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
11.5
1%
11.5
IE
E
Endo International PLC
LSE:0Y5F
830.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.1
8%
1.3